A substantial portion of Active Pharmaceutical Ingredients (APIs) used in India’s drug production originates from China.
APIs are essential for drug formulation, and global supply chains influence manufacturing costs and availability.
Efforts are ongoing to boost domestic API production to reduce dependence on imports.